CYCLACEL LIMITED

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 19236
 
  
 
C07D HETEROCYCLIC COMPOUNDS 12150
 
  
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 590
 
  
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 247
 
  
 
C07C ACYCLIC OR CARBOCYCLIC COMPOUNDS 2136
 
  
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 297
 
  
 
G01F MEASURING VOLUME, VOLUME FLOW, MASS FLOW, OR LIQUID LEVEL; METERING BY VOLUME 257
 
  
 
G01P MEASURING LINEAR OR ANGULAR SPEED, ACCELERATION, DECELERATION, OR SHOCK; INDICATING PRESENCE, ABSENCE, OR DIRECTION, OF MOVEMENT 255
 
  
 
G06F ELECTRIC DIGITAL DATA PROCESSING 1446
 
  
 
H04M TELEPHONIC COMMUNICATION 1162

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

  • No Recent Publications to Display

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9872874 Dosage regimen for sapacitabine and seliciclibMay 14, 13Jan 23, 18[A61K]
9675631 Dosing regimens for treatment of proliferative disorders comprising administration of sapacitabineAug 15, 13Jun 13, 17[A61K]
9573951 Crystalline forms of a purine derivativeOct 27, 14Feb 21, 17[A61K, C07D, C07C, G01P, G01F]
9493471 Pyrimidine derivatives as protein kinase inhibitorsAug 07, 15Nov 15, 16[A61K, C07D]
9173938 Combination of a purine-based CDK inhibitor with a tyrosine kinase inhibitor and use thereof in the treatment of proliferative disordersOct 05, 09Nov 03, 15[A61K, C07D]
9133199 Pyrimidine derivatives as protein kinase inhibitorsJun 05, 13Sep 15, 15[A61K, C07D]
8975239 Combinations of sapacitabine or CNDAC with DNA methyltransferase inhibitors such as decitabine and procaineAug 06, 13Mar 10, 15[A61K, A01N]
8889861 Crystalline forms of a purine derivativeJan 24, 11Nov 18, 14[A61K, C07D, C07C, G01P, G01F]
8884001 Preparation of intermediates useful in the synthesis of 2′-cyano-2′-deoxy-N4-palmi-toyl-1-β-D-arabinofuranosylcytosineMay 08, 09Nov 11, 14[C07H, C07F]
8809350 Purine and pyrimidine CDK inhibitors and their use for the treatment of autoimmune diseasesMay 04, 12Aug 19, 14[A61K]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2015/0320,762 TREATMENT OF PROLIFERATIVE DISEASES WITH PYRIMIDODIAZEPINONESAbandonedMar 28, 13Nov 12, 15[A61K]
2013/0196,938 COMBINATION COMPRISING CNDAC (2'-CYANO-2'-DEOXY-N4-PALMITOYL-1-BETA-D-ARABINOFURANOSYL-CYTOSINE) AND A CYTOTOXIC AGENTAbandonedDec 10, 12Aug 01, 13[A61K]
2013/0005,747 METHOD FOR SELECTING A CANCER THERAPYAbandonedDec 21, 11Jan 03, 13[A61K, C12Q, A61P]
2009/0318,446 4-(1H-Indol-3-yl)-Pyrimidin-2-Ylamine Derivatives and Their Use in TherapyAbandonedJan 11, 06Dec 24, 09[A61K, C07D, G01N, A61P]
2009/0306,098 COMBINATION OF ROSCOVITINE AND A HDCA INHIBITOR TO TREAT PROLIFERATIVE DISEASESAbandonedNov 13, 06Dec 10, 09[A61K, A61P]
2009/0274,773 ANTIPROLIFERATIVE COMBINATION COMPRISING CYC-682 AND A CYTOTOXIC AGENTAbandonedNov 13, 06Nov 05, 09[A61K, A61P]
2009/0215,805 4-Heteroaryl Pyrimidine Derivatives and use thereof as Protein Kinase InhibitorsAbandonedOct 09, 06Aug 27, 09[A61K, C07D, G01N, A61P]
7576091 Thiazolo-, oxazalo and imidazolo-quinazoline compounds capable of inhibiting protein kinasesExpiredJan 06, 06Aug 18, 09[A61K, A01N, C07D]
2009/0137,572 2-substituted-4-heteroaryl-pyrimidines useful for the treatment of proliferative disordersAbandonedMay 26, 05May 28, 09[A61K]
2008/0318,954 CompoundsAbandonedFeb 07, 05Dec 25, 08[A61K, C07D, A61P]
7449544 p21 peptidesExpiredMay 19, 03Nov 11, 08[C07K]
2008/0249,025 Methods and Means For Inhibition of CDK4 ActivityAbandonedJun 04, 08Oct 09, 08[A61K, C12N, A61P]
2008/0167,385 Crystal Structure of Human Proliferating Cell Nuclear Antigen (Pcna) and Uses ThereofAbandonedMay 10, 05Jul 10, 08[A61K, C12N, G01N, A61P, G06G, C40B, C07K]
2008/0132,484 Method for Identifying Inhibitors Using a Homology Model of Polo-Like Kinase 1AbandonedNov 12, 04Jun 05, 08[A61K, C12Q, C12N, G06T, G06F, A61P]
2008/0125,404 Purine and Pyrimidine Cdk Inhitbitors and Their use for The Treatment of Autoimmune DiseasesAbandonedAug 25, 05May 29, 08[A61K, A61P]
7312356 MedicamentExpiredMay 14, 04Dec 25, 07[C07C]
2007/0287,718 Methods for the Treatment of Multiple Myeloma Using RoscovitineAbandonedNov 08, 04Dec 13, 07[A61K, A61P]
2007/0269,433 Cell cycle progressional proteinsAbandonedDec 05, 06Nov 22, 07[A61K, C07H, C12Q, C12N, G01N, C07K]
7262202 Inhibitors of cyclin dependent kinases as anti-cancer agentExpiredSep 24, 03Aug 28, 07[C07D]
2007/0185,134 Inhibitors of cyclin dependent kinases as anti-cancer agentAbandonedAug 21, 06Aug 09, 07[A61K, C07D]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.